Nuclear antigens and auto/alloantibody responses: Friend or Foe in transplant immunology

Toshiaki Nakano*, Chao Long Chen, Shigeru Goto

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

In addition to cellular immune responses, humoral immune responses, mediated by natural antibodies, autoantibodies, and alloantibodies, have increasingly been recognized as causes of organ transplant rejection. In our previous studies, we have demonstrated the induction of antinuclear antibodies against histone H1 and high-mobility group box 1 (HMGB1), in both experimental and clinical liver transplant tolerance. The active induction of antinuclear antibodies is usually an undesirable phenomenon, but it is often observed after liver transplantation. However, the release of nuclear antigens and its suppression by neutralizing antibodies are proposed to be important in the initiation and regulation of immune responses. In this review article, we summarize the current understanding of nuclear antigens and corresponding antinuclear regulatory antibodies (Abregs) on infection, injury, inflammation, transplant rejection, and tolerance induction and discuss the significance of nuclear antigens as diagnostic and therapeutic targets.

Original languageEnglish
Article number267156
JournalClinical and Developmental Immunology
Volume2013
DOIs
StatePublished - 2013

Fingerprint

Dive into the research topics of 'Nuclear antigens and auto/alloantibody responses: Friend or Foe in transplant immunology'. Together they form a unique fingerprint.

Cite this